Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes
Type 1 diabetes (T1D) is a common chronic illness among children requiring a high degree of self-management for good glycemic control. Adolescents are at risk for poor disease management and health outcomes due to a number of factors, including high rates of depression, anxiety, and stress. Accessing support for these challenges can be a barrier to care, so the current study, BRinging Empowerment and Attention to Teen HEalth-T1D, evaluates the efficacy of a virtual, group-based mindfulness based intervention and a…
Conditions studied
Type 1 Diabetes (T1D)
About this study
Type 1 diabetes (T1D) is a common chronic illness among children requiring a high degree of self-management for good glycemic control. Adolescents are at risk for poor disease management and health outcomes due to a number of factors, including high rates of depression, anxiety, and stress. Accessing support for these challenges can be a barrier to care, so the current study, BRinging Empowerment and Attention to Teen HEalth-T1D, evaluates the efficacy of a virtual, group-based mindfulness based intervention and a virtual group-based diabetes education intervention on improving symptoms of depression and anxiety, and diabetes self management in teens with T1D. The study also aims to study how these interventions might be implemented in diabetes clinic settings.
Interventions
- Behavioral: BREATHE-T1D — BREATHE-T1D was adapted from Learning to BREATHE, a group mindfulness-based intervention for teens. It teaches mindfulness strategies adapted to be specific and relatable to, teens with T1D to improves symptoms of depression and anxiety as well as diabetes self-management.
- Behavioral: HealthEd-T1D — HealthEd-T1D is a 6 week, virtual, group based diabetes education group.
Primary outcomes
- Glycemic control (Baseline, 3-, and 12-months post intervention)
- Depression (Baseline, 3-, and 12-months post intervention)
Eligibility information
Study locations
- Barbara Davis Center, Aurora, Colorado 80045 United States
- Children's National Hospital, Washington D.C., District of Columbia 20010 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-15.